Work

Phase 2 study of lenvatinib (LN) in patients (Pts) with RET fusion-positive adenocarcinoma of the lung

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw383.05

Authors: V. Velcheti, T. Hida, K.L. Reckamp, J.C. Yang, H. Nokihara, P. Sachdev, K. Feit, T. Kubota, T. Nakada, C.E. Dutcus, M. Ren, T. Tamura

Institutions: Cleveland Clinic, Aichi Cancer Center Hospital, City Of Hope National Medical Center, City of Hope, National Taiwan University Hospital, National Cancer Center Hospital, Eisai (United States), Eisai (Japan), St. Luke's International Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2587750143

FWCI: 8.648

Cites:

Cited by: 42

Related to: 10